Michael Parini, EVP, CL&AO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,992 shares at $238.30 ($1.9M) on 2020-02-25, disclosed to the SEC on 2020-02-26.
Seasonal sale ($1.9M) by EVP, CL&AO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $239.23 | 2,416 | $578K | 30.8% |
| 2 | $230.07 | 938 | $216K | 11.5% |
| 3 | $230.07 | 938 | $216K | 11.5% |
| 4 | $231.62 | 330 | $76K | 4.1% |
| 5 | $231.62 | 330 | $76K | 4.1% |
| 6 | $232.89 | 320 |
| $75K |
| 4.0% |
| 7 | $232.89 | 320 | $75K | 4.0% |
| 8 | $234.77 | 640 | $150K | 8.0% |
| 9 | $234.77 | 640 | $150K | 8.0% |
| 10 | $236.26 | 320 | $76K | 4.0% |
| 11 | $236.26 | 320 | $76K | 4.0% |
| 12 | $238.30 | 480 | $114K | 6.1% |
| Total | $234.94 avg | 7,992 | $1.9M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $1.7M | — | Filing → |
| VRTX | SELL | 2021-02-09 | $415K | — | Filing → |
| VRTX | SELL | 2021-02-05 | $87K | — | Filing → |